[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Mirati Therapeutics (MRTX)

Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Income Statement for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)
  06-2007 03-2007 12-2006 09-2006 06-2006
Sales 3,320 3,020 2,990 7,650 2,290
Cost of Goods 0 0 -4,060 0 0
Gross Profit 3,320 3,020 7,040 7,650 2,290
Operating Expenses 8,884 6,454 10,307 4,035 1,815
Operating Income -5,564 -3,434 -3,317 3,616 476
Other Income -76 664 1,187 695 -226
Pre-tax Income -5,640 -2,770 -2,130 4,310 250
Income Tax 0 0 10 1,610 3,800
Net Income Continuous -5,640 -2,770 -2,130 2,690 -3,550
Net Income $-5,640 $-2,770 $-2,130 $2,690 $-3,550
EBITDA(a) $-5,204 $-3,114 $-2,957 $3,946 $796
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.